Literature DB >> 11459086

Immunohistochemical localisation of cytokeratins in craniopharyngioma.

M Kurosaki1, W Saeger, D K Lüdecke.   

Abstract

BACKGROUND: Although craniopharyngiomas have been examined in several microscopical studies to date, immunohistochemical analysis has not been sufficient.
METHOD: In addition to the routine haematoxylin and eosin staining, 38 cases of intra- and/or supra-sellar craniopharyngioma, including 34 adamatinomatous and 4 squamous papillary types, were studied using immunohistochemistry for expression of four types of cytokeratin.
FINDINGS: Histological examination found epithelial cells in 26 of 38 (68.40%) cases. However, cytokeratins were demonstrated in 35 of 38 (92.1%) cases. The remaining 3 cases without demonstration of epithelial cell nests were supposed to be adamantinomatous craniopharyngiomas based on the findings in the stroma. In 31 of 34 adamantinomatous craniopharyngioma cases, the epithelium was detected by immunostaining for cytokeratins. The epithlieum expressed 56 kDa (KL-1) and 40 kDa (cytokeratin 19) cytokeratins with similar staining patterns and intensities. The staining intensity of 54 kDa cytokeratin (cytokeratin 7) was similar to that of the high molecular weight cytokeratin (keratin M-903). However, in many cases (15 of 27), immunoreactivity of cytokeratin 7 was not demonstrated in an outer palisaded basal layer. In all 4 squamous papillary craniopharyngiomas, moderate staining with cytokeratin 7 appeared in the superficial layer, whereas basal or mid-zone epithelial cells were negative for cytokeratin 7. The basal layer stained negatively for KL-1, as well as cytokeratin 7.
INTERPRETATION: Immunostaining for cytokeratin is valuable in the investigation of craniopharyngioma, especially when specimens contain only a small or questionable part of epithelium. Most notably, KL-1 or cytokeratin 7 stainings are suitable for analyzing these tumours, with special reference to histological subtypes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11459086     DOI: 10.1007/s007010170120

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  6 in total

Review 1.  [New aspects of tumor pathology of the pituitary].

Authors:  W Saeger
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

2.  Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.

Authors:  Yuelong Wang; Jiaojiao Deng; Gang Guo; Aiping Tong; Xirui Peng; Haifeng Chen; Jianguo Xu; Yi Liu; Chao You; Liangxue Zhou
Journal:  J Neurooncol       Date:  2016-09-17       Impact factor: 4.130

Review 3.  [Pituitary gland tumors].

Authors:  W Saeger
Journal:  Pathologe       Date:  2003-05-29       Impact factor: 1.011

Review 4.  [Space occupying processes of the sellar region with emphasis on tumor-like lesions].

Authors:  W Saeger
Journal:  Pathologe       Date:  2003-05-29       Impact factor: 1.011

5.  Hormone markers in pituitary adenomas: changes within last decade resulting from improved method.

Authors:  Wolfgang Saeger; Waldemar Wilczak; Dieter K Lüdecke; Michael Buchfelder; Rudolf Fahlbusch
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

6.  Comparative immunohistochemical assessment of craniopharyngioma and related lesions.

Authors:  Brian H Le; Javad Towfighi; Silloo B Kapadia; M Beatriz S Lopes
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.